Cargando…

Fatty Acid Amide Hydrolase (FAAH) Inhibitors Exert Pharmacological Effects, but Lack Antinociceptive Efficacy in Rats with Neuropathic Spinal Cord Injury Pain

Amelioration of neuropathic spinal cord injury (SCI) pain is a clinical challenge. Increasing the endocannabinoid anandamide and other fatty acid amides (FAA) by blocking fatty acid amide hydrolase (FAAH) has been shown to be antinociceptive in a number of animal models of chronic pain. However, an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hama, Aldric T., Germano, Peter, Varghese, Matthew S., Cravatt, Benjamin F., Milne, G. Todd, Pearson, James P., Sagen, Jacqueline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008577/ https://www.ncbi.nlm.nih.gov/pubmed/24788435 http://dx.doi.org/10.1371/journal.pone.0096396

Ejemplares similares

Effects of repeated dosing with mechanistically distinct antinociceptive ligands in a rat model of neuropathic spinal cord injury pain
por: Hama, Aldric T, et al.
Publicado: (2014)

Antinociceptive effects of topical mepivacaine in a rat model of HIV-associated peripheral neuropathic pain
por: Sagen, Jacqueline, et al.
Publicado: (2016)

Selective antinociceptive effects of a combination of the N-methyl-D-aspartate receptor peptide antagonist [Ser(1)]histogranin and morphine in rat models of pain
por: Hama, Aldric, et al.
Publicado: (2014)

Combination Drug Therapy for Pain following Chronic Spinal Cord Injury
por: Hama, Aldric, et al.
Publicado: (2012)

The Molecular Basis for Dual Fatty Acid Amide Hydrolase (FAAH)/Cyclooxygenase (COX) Inhibition
por: Palermo, Giulia, et al.
Publicado: (2015)

The endocannabinoid hydrolase FAAH is an allosteric enzyme
por: Dainese, Enrico, et al.
Publicado: (2020)

Fatty Acid Amide Hydrolase (FAAH) Inhibition Modulates Amyloid-Beta-Induced Microglia Polarization
por: Grieco, Maddalena, et al.
Publicado: (2021)

N-aryl 2-aryloxyacetamides as a new class of fatty acid amide hydrolase (FAAH) inhibitors
por: Sunduru, Naresh, et al.
Publicado: (2017)

Mutation screen and association studies for the fatty acid amide hydrolase (FAAH) gene and early onset and adult obesity
por: Müller, Timo D, et al.
Publicado: (2010)

Fatty Acid Amide Hydrolase (FAAH) Inhibition Plays a Key Role in Counteracting Acute Lung Injury
por: Genovese, Tiziana, et al.
Publicado: (2022)

A genetic variant of fatty acid amide hydrolase (FAAH) exacerbates hormone-mediated orexigenic feeding in mice
por: Balsevich, Georgia, et al.
Publicado: (2023)

Author Correction: The endocannabinoid hydrolase FAAH is an allosteric enzyme
por: Dainese, Enrico, et al.
Publicado: (2020)

Pharmacological blockade of the fatty acid amide hydrolase (FAAH) alters neural proliferation, apoptosis and gliosis in the rat hippocampus, hypothalamus and striatum in a negative energy context
por: Rivera, Patricia, et al.
Publicado: (2015)

Assessment of NSAIDs as potential inhibitors of the fatty acid amide hydrolase I (FAAH-1) using three different primary fatty acid amide substrates in vitro
por: Dongdem, Julius T., et al.
Publicado: (2022)

Gaps in Understanding Mechanism and Lack of Treatments: Potential Use of a Nonhuman Primate Model of Oxaliplatin-Induced Neuropathic Pain
por: Hama, Aldric, et al.
Publicado: (2018)

A Personal Retrospective: Elevating Anandamide (AEA) by Targeting Fatty Acid Amide Hydrolase (FAAH) and the Fatty Acid Binding Proteins (FABPs)
por: Deutsch, Dale G.
Publicado: (2016)

Inhibition of Fatty Acid Amide Hydrolase (FAAH) Regulates NF-kb Pathways Reducing Bleomycin-Induced Chronic Lung Inflammation and Pulmonary Fibrosis
por: Genovese, Tiziana, et al.
Publicado: (2023)

Fatty Acid Amide Hydrolase-Dependent Generation of Antinociceptive Drug Metabolites Acting on TRPV1 in the Brain
por: Barrière, David A., et al.
Publicado: (2013)

Potential of Fatty Acid Amide Hydrolase (FAAH), Monoacylglycerol Lipase (MAGL), and Diacylglycerol Lipase (DAGL) Enzymes as Targets for Obesity Treatment: A Narrative Review
por: Matheson, Justin, et al.
Publicado: (2021)

Pharmacological comparison of a nonhuman primate and a rat model of oxaliplatin‐induced neuropathic cold hypersensitivity
por: Shidahara, Yuka, et al.
Publicado: (2016)

The effects of inhibition of fatty acid amide hydrolase (FAAH) by JNJ-42165279 in social anxiety disorder: a double-blind, randomized, placebo-controlled proof-of-concept study
por: Schmidt, Mark E., et al.
Publicado: (2020)

Teneligliptin Exerts Antinociceptive Effects in Rat Model of Partial Sciatic Nerve Transection Induced Neuropathic Pain
por: Kuthati, Yaswanth, et al.
Publicado: (2021)

A pro-nociceptive phenotype unmasked in mice lacking fatty-acid amide hydrolase
por: Carey, Lawrence M, et al.
Publicado: (2016)

Design, Synthesis, and Characterization of α-Ketoheterocycles That Additionally Target the Cytosolic Port Cys269 of Fatty Acid Amide Hydrolase
por: Otrubova, Katerina, et al.
Publicado: (2014)

Combining fatty acid amide hydrolase (FAAH) inhibition with peroxisome proliferator-activated receptor (PPAR) activation: a new potential multi-target therapeutic strategy for the treatment of Alzheimer’s disease
por: Brunetti, Leonardo, et al.
Publicado: (2019)

A New Series of Aryloxyacetic Acids Endowed with Multi-Target Activity towards Peroxisome Proliferator-Activated Receptors (PPARs), Fatty Acid Amide Hydrolase (FAAH), and Acetylcholinesterase (AChE)
por: Leuci, Rosalba, et al.
Publicado: (2022)

Preclinical pharmacological evaluation of the fatty acid amide hydrolase inhibitor BIA 10‐2474
por: Bonifácio, Maria‐João, et al.
Publicado: (2020)

FAAH genetic variation enhances fronto-amygdala function in mouse and human
por: Dincheva, Iva, et al.
Publicado: (2015)

A Systems Pharmacology Perspective on the Clinical Development of Fatty Acid Amide Hydrolase Inhibitors for Pain
por: Benson, N, et al.
Publicado: (2014)

FAAH inhibitors in the limelight, but regrettably
por: Mallet, Christophe, et al.
Publicado: (2016)

Three-Dimensional Quantitative Structure-Activity Relationships (3D-QSAR) on a Series of Piperazine-Carboxamides Fatty Acid Amide Hydrolase (FAAH) Inhibitors as a Useful Tool for the Design of New Cannabinoid Ligands
por: Lorca, Marcos, et al.
Publicado: (2019)

Involvement of Fatty Acid Amide Hydrolase and Fatty Acid Binding Protein 5 in the Uptake of Anandamide by Cell Lines with Different Levels of Fatty Acid Amide Hydrolase Expression: A Pharmacological Study
por: Björklund, Emmelie, et al.
Publicado: (2014)

Ketoconazole Inhibits the Cellular Uptake of Anandamide via Inhibition of FAAH at Pharmacologically Relevant Concentrations
por: Björklund, Emmelie, et al.
Publicado: (2014)

GPR18 drives FAAH inhibition-induced neuroprotection against HIV-1 Tat-induced neurodegeneration
por: Hermes, Douglas J., et al.
Publicado: (2021)

Interaction of the N-(3-Methylpyridin-2-yl)amide Derivatives of Flurbiprofen and Ibuprofen with FAAH: Enantiomeric Selectivity and Binding Mode
por: Karlsson, Jessica, et al.
Publicado: (2015)

Antinociceptive Effects of Amiloride and Benzamil in Neuropathic Pain Model Rats
por: Jeong, Seongtae, et al.
Publicado: (2013)

Antinociceptive effects of sinomenine in a rat model of neuropathic pain
por: Zhu, Qing, et al.
Publicado: (2014)

Antinociceptive Effect of Magnolol in a Neuropathic Pain Model of Mouse
por: Zhang, Xiao, et al.
Publicado: (2021)

Design and Potency of Dual Soluble Epoxide Hydrolase/Fatty Acid Amide Hydrolase Inhibitors
por: Kodani, Sean D., et al.
Publicado: (2018)

FAAH selectively influences placebo effects
por: Peciña, M., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_fbjgtu7miuv1lh54l9q90aqje7